Global Med Technologies(R), Inc. Chosen as the Bowser Report's Company of the Month
August 28 2007 - 9:00AM
PR Newswire (US)
DENVER, Aug. 28 /PRNewswire-FirstCall/ -- Global Med
Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) , a rapidly
expanding International e-Health medical information technology
company providing information management software products and
services to the healthcare industry, has been chosen "Company of
the Month" for August, 2007, by The Bowser Report newsletter. The
Bowser Report is a subscription-based newsletter paid for solely by
its readers. Neither research nor coverage is paid for by the
companies featured in the publication. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) "The
Bowser Report's (and its readers') choice is truly gratifying,"
said CEO Michael I. Ruxin, M.D. "It is a rewarding recognition of
our rapid growth to 634 sites domestically and internationally as a
leading supplier of information management systems to U.S. and
international blood centers and hospital transfusion centers that
include such clients as Mayo Clinic, Memorial Sloan-Kettering
Cancer Center, Stanford University Medical School, New York
Presbyterian Hospital, Los Angeles' Cedars-Sinai Health System, and
Pittsburgh's Institute for Transfusion Medicine." The Bowser Report
is a monthly ten-page newsletter that recommends stocks trading at
$3.00 a share or less on the NYSE, NASDAQ, AMEX and OTCBB. It is
considered one of the investment community's top ten news letters.
Only one "Company of the Month" is highlighted in each issue. The
publication is now in its 30th year. Recently a European version of
The Bowser Report was launched. Max Bowser, founder, has authored
three widely read books. The third edition of "Making Dollars with
Pennies," will be published later this year. About Global Med
Technologies, Inc. Global Med Technologies(R), Inc. is an
international e-Health medical information technology company
providing information management software products and services to
the healthcare industry. Its Wyndgate Technologies(R) division is a
leading supplier of information management systems to U.S. and
international blood centers and hospital transfusion centers. Each
year, Wyndgate's products and services manage more than eight
million blood components, representing over 27% of the U.S. blood
supply. Wyndgate's products are being used in Canada and
sub-Saharan Africa, and are being implemented in the Caribbean.
Together, the Donor Doc(TM) interactive donor health history
questionnaire, SafeTrace(R) donor management system, and the
SafeTrace Tx(R) advanced transfusion management system, recently
patented, provide Vein-to-Vein(R) tracking from donor collection to
patient transfusion. For more information about Global Med's
products and services, please call 800-WYNDGATE or visit
http://www.globalmedtech.com/, peoplemed.com, and
http://www.wyndgate.com/. This news release may include statements
that constitute forward-looking statements, usually containing the
words "believe," "estimate," "project," "expects" or similar
expressions. These statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies(R),
Inc. CONTACT: company, Michael I. Ruxin, M.D. of Global Med
Technologies, Inc., +1-303-238-2000; or investors, Paul Holm of
H.L. Lanzet, +1-212-888-4570, , for Global Med Technologies(R),
Inc. Web site: http://www.globalmedtech.com/
http://www.wyndgate.com/
Copyright